↓ Skip to main content

PLOS

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells

Overview of attention for article published in PLOS ONE, August 2014
Altmetric Badge

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
27 X users
patent
3 patents
facebook
14 Facebook pages
wikipedia
4 Wikipedia pages
googleplus
1 Google+ user
reddit
2 Redditors
video
2 YouTube creators

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
224 Mendeley
citeulike
1 CiteULike
Title
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
Published in
PLOS ONE, August 2014
DOI 10.1371/journal.pone.0106533
Pubmed ID
Authors

Attila Szabo, Attila Kovacs, Ede Frecska, Eva Rajnavolgyi

Abstract

The orphan receptor sigma-1 (sigmar-1) is a transmembrane chaperone protein expressed in both the central nervous system and in immune cells. It has been shown to regulate neuronal differentiation and cell survival, and mediates anti-inflammatory responses and immunosuppression in murine in vivo models. Since the details of these findings have not been elucidated so far, we studied the effects of the endogenous sigmar-1 ligands N,N-dimethyltryptamine (NN-DMT), its derivative 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and the synthetic high affinity sigmar-1 agonist PRE-084 hydrochloride on human primary monocyte-derived dendritic cell (moDCs) activation provoked by LPS, polyI:C or pathogen-derived stimuli to induce inflammatory responses. Co-treatment of moDC with these activators and sigma-1 receptor ligands inhibited the production of pro-inflammatory cytokines IL-1β, IL-6, TNFα and the chemokine IL-8, while increased the secretion of the anti-inflammatory cytokine IL-10. The T-cell activating capacity of moDCs was also inhibited, and dimethyltryptamines used in combination with E. coli or influenza virus as stimulators decreased the differentiation of moDC-induced Th1 and Th17 inflammatory effector T-cells in a sigmar-1 specific manner as confirmed by gene silencing. Here we demonstrate for the first time the immunomodulatory potential of NN-DMT and 5-MeO-DMT on human moDC functions via sigmar-1 that could be harnessed for the pharmacological treatment of autoimmune diseases and chronic inflammatory conditions of the CNS or peripheral tissues. Our findings also point out a new biological role for dimethyltryptamines, which may act as systemic endogenous regulators of inflammation and immune homeostasis through the sigma-1 receptor.

X Demographics

X Demographics

The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 224 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Hungary 1 <1%
Brazil 1 <1%
Finland 1 <1%
United Kingdom 1 <1%
United States 1 <1%
Poland 1 <1%
Unknown 218 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 15%
Student > Ph. D. Student 31 14%
Student > Bachelor 30 13%
Student > Master 28 13%
Other 14 6%
Other 30 13%
Unknown 57 25%
Readers by discipline Count As %
Neuroscience 29 13%
Agricultural and Biological Sciences 24 11%
Psychology 23 10%
Medicine and Dentistry 19 8%
Biochemistry, Genetics and Molecular Biology 17 8%
Other 47 21%
Unknown 65 29%